当前位置:首页 - 行情中心 - 泽璟制药-U(688266) - 财务分析

泽璟制药-U

(688266)

  

流通市值:284.83亿  总市值:284.83亿
流通股本:2.65亿   总股本:2.65亿

泽璟制药-U(688266)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.29亿元,每股收益-0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益122372.99万元,未分配利润-214500.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产291782.39万元,负债169409.40万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入167,641,962.39532,954,371.3384,117,191.62240,696,731.58
营业总成本224,891,718.58726,897,941.91509,620,185.43330,471,226.37
营业利润-30,017,022.32-155,043,183.78-112,548,101.52-79,435,959.33
利润总额-30,317,022.32-155,047,806.79-112,602,724.53-79,493,376.06
净利润-29,313,362.27-150,298,322.91-109,646,565.01-77,527,664.35
其他综合收益140,191.46-8,749,199.6926,035,078.95338,774.7
综合收益总额-29,173,170.81-159,047,522.6-83,611,486.06-77,188,889.65
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,496,560,281.492,575,898,809.82,565,243,592.542,705,741,942.97
非流动资产合计421,263,599.42428,715,474.18401,904,317.46393,921,082.11
资产总计2,917,823,880.913,004,614,283.982,967,147,9103,099,663,025.08
流动负债合计1,325,481,564.641,373,445,525.831,313,676,788.181,169,133,070.04
非流动负债合计368,612,453.87378,568,209.03350,665,123.57362,163,991.46
负债合计1,694,094,018.511,752,013,734.861,664,341,911.751,531,297,061.5
归属于母公司股东权益合计1,226,013,046.531,253,857,931.481,303,387,496.251,567,044,488.52
股东权益合计1,223,729,862.41,252,600,549.121,302,805,998.251,568,365,963.58
负债和股东权益合计2,917,823,880.913,004,614,283.982,967,147,9103,099,663,025.08
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计216,781,433.79872,829,012.32702,864,034.36540,162,054.19
经营活动现金流出小计223,034,586.21834,624,467.53636,216,963.79427,608,991.08
经营活动产生的现金流量净额-6,253,152.4238,204,544.7966,647,070.57112,553,063.11
投资活动现金流入小计7,177,4001,217,088,569.191,016,865,822.15799,264,489.27
投资活动现金流出小计33,808,123.123,062,189,956.331,008,410,550.44763,676,661.49
投资活动产生的现金流量净额-26,630,723.12-1,845,101,387.148,455,271.7135,587,827.78
筹资活动现金流入小计141,321,903.341,288,618,503.6798,000,000528,000,000
筹资活动现金流出小计173,118,011.281,339,934,919.14876,125,567.19483,635,207.12
筹资活动产生的现金流量净额-31,796,107.94-51,316,415.54-78,125,567.1944,364,792.88
汇率变动对现金及现金等价物的影响-9,211.92-2,298,440.51-536,724.6737,025.92
现金及现金等价物净增加额-64,689,195.4-1,860,511,698.4-3,559,949.58192,542,709.69
期末现金及现金等价物余额152,576,297.68217,265,493.082,074,217,241.92,270,319,901.17
最新报告期:2025-04-21
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
财通证券华挺,赵千,张文录0.081.272.692025-04-21
国联民生夏禹,郑薇-0.230.691.162025-04-21
华安证券谭国超0.241.913.812025-04-20
海通证券彭娉,余文心-0.200.17--2025-03-06
TOP↑